Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 1,880 | 1,071 | 1,555 | 2,485 | 552 |
| Operating Income | -1,880 | -1,071 | -1,555 | -2,485 | -552 |
| Interest Expense | 0 | 0 | 0 | 12 | 0 |
| Other Income | 3 | -2 | 2 | -26,615 | -4 |
| Pre-tax Income | -1,877 | -1,073 | -1,553 | -29,112 | -556 |
| Net Income Continuous | -1,877 | -1,073 | -1,553 | -29,112 | -556 |
| Net Income | $-1,877 | $-1,073 | $-1,553 | $-29,112 | $-556 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.07 | -1.59 | -0.68 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.07 | -1.59 | -0.04 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.07 | -1.59 | -0.68 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.07 | -1.59 | -0.04 |
| EBITDA(a) | $-1,880 | $-1,071 | $-1,555 | $-2,485 | $-552 |